BR9815501A - Derivados de prostaglandina isentos de efeitos colaterais para o tratamento de glaucoma - Google Patents

Derivados de prostaglandina isentos de efeitos colaterais para o tratamento de glaucoma

Info

Publication number
BR9815501A
BR9815501A BR9815501-6A BR9815501A BR9815501A BR 9815501 A BR9815501 A BR 9815501A BR 9815501 A BR9815501 A BR 9815501A BR 9815501 A BR9815501 A BR 9815501A
Authority
BR
Brazil
Prior art keywords
glaucoma
treatment
side effects
prostaglandin derivatives
derivatives free
Prior art date
Application number
BR9815501-6A
Other languages
English (en)
Inventor
Johan Stjernschantz
Bahram Resul
Staffan Lake
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9815501(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of BR9815501A publication Critical patent/BR9815501A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<B>"DERIVADOS DE PROSTAGLANDINA ISENTOS DE EFEITOS COLATERAIS PARA O TRATAMENTO DE GLAUCOMA"<D>. A invenção descreve um novo método e composições para o tratamento de glaucoma e hipertensão ocular. O método se baseia no uso de agonistas prostanóides receptores de EP~ 1~, que efetivamente reduzem a pressão intraocular, mas, que não apresentam qualquer efeito ou apenas um efeito reduzido sobre a pigmentação da íris. O análogo de prostaglandina que é um agonista seletivo de EP~ 1~ é aplicado topicamente sobre o olho.
BR9815501-6A 1997-07-11 1998-07-10 Derivados de prostaglandina isentos de efeitos colaterais para o tratamento de glaucoma BR9815501A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702706A SE9702706D0 (sv) 1997-07-11 1997-07-11 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
PCT/SE1998/001368 WO1999002165A1 (en) 1997-07-11 1998-07-10 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma

Publications (1)

Publication Number Publication Date
BR9815501A true BR9815501A (pt) 2001-07-17

Family

ID=20407743

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815501-6A BR9815501A (pt) 1997-07-11 1998-07-10 Derivados de prostaglandina isentos de efeitos colaterais para o tratamento de glaucoma

Country Status (18)

Country Link
EP (1) EP1014991A1 (pt)
JP (1) JP2002509543A (pt)
KR (1) KR20010021682A (pt)
CN (1) CN1169528C (pt)
AU (1) AU739828B2 (pt)
BR (1) BR9815501A (pt)
CA (1) CA2294779A1 (pt)
HU (1) HUP0003106A3 (pt)
IL (1) IL133871A (pt)
IS (1) IS5333A (pt)
NO (1) NO20000062D0 (pt)
NZ (1) NZ501834A (pt)
PL (1) PL337940A1 (pt)
RU (1) RU2207858C2 (pt)
SE (1) SE9702706D0 (pt)
SK (1) SK183499A3 (pt)
TR (1) TR200000008T2 (pt)
WO (1) WO1999002165A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803761D0 (sv) * 1998-11-04 1998-11-04 Synphora Ab Method to avoid increased iridial pigmentation during prostaglandin treatment
CA2364948C (en) 1999-03-05 2011-04-26 Duke University C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US6713268B2 (en) * 2001-06-26 2004-03-30 Allergan, Inc. Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
US7456274B2 (en) * 2002-09-16 2008-11-25 Texas Tech University System Inhibition of metallo-β-lactamase
US7091231B2 (en) * 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
PL212658B1 (pl) * 2005-04-18 2012-11-30 Inst Farmaceutyczny Sposób otrzymywania pochodnych 13,14-dihydro-PGF<sub>2</sub><sub>α</sub>
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
JPWO2009133863A1 (ja) 2008-04-28 2011-09-01 国立大学法人浜松医科大学 Ｅｐ１アゴニストを含有してなる免疫増強剤
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
WO2010126626A2 (en) 2009-05-01 2010-11-04 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
US8901319B2 (en) 2009-10-16 2014-12-02 Cayman Chemical Company, Incorporated Process for the preparation of F-series prostaglandins
HRP20160908T1 (hr) 2012-03-28 2016-09-23 Merck Patent Gmbh Biciklički derivati pirazinona
JP2012246301A (ja) * 2012-08-10 2012-12-13 Cayman Chemical Co Inc Ｆ系プロスタグランジン類を調製する方法
ES2776199T3 (es) 2013-03-15 2020-07-29 Aerie Pharmaceuticals Inc Conjugados de compuestos de isoquinolina y prostaglandinas
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
WO2018045091A1 (en) 2016-08-31 2018-03-08 Aerie Pharmaceuticals, Inc. Ophthalmic compositions
CA3057872A1 (en) 2017-03-31 2018-10-04 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
AU2019337703B2 (en) 2018-09-14 2023-02-02 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085272A (en) * 1977-03-30 1978-04-18 American Cyanamid Company 11-(2-Hydroxyethylthio)prostenoic acid E2 series derivatives
US4132738A (en) * 1978-02-23 1979-01-02 Miles Laboratories, Inc. Preparation of 15-deoxy-16-hydroxyprostaglandins
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
ES2105333T3 (es) * 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.

Also Published As

Publication number Publication date
WO1999002165A1 (en) 1999-01-21
HUP0003106A2 (hu) 2001-01-29
CN1169528C (zh) 2004-10-06
IL133871A (en) 2004-09-27
NO20000062L (no) 2000-01-06
CN1262623A (zh) 2000-08-09
SE9702706D0 (sv) 1997-07-11
HK1029942A1 (en) 2001-04-20
KR20010021682A (ko) 2001-03-15
IS5333A (is) 2000-01-07
SK183499A3 (en) 2000-07-11
NO20000062D0 (no) 2000-01-06
EP1014991A1 (en) 2000-07-05
JP2002509543A (ja) 2002-03-26
RU2207858C2 (ru) 2003-07-10
TR200000008T2 (tr) 2000-05-22
HUP0003106A3 (en) 2002-12-28
AU739828B2 (en) 2001-10-18
CA2294779A1 (en) 1999-01-21
AU8368398A (en) 1999-02-08
IL133871A0 (en) 2001-04-30
NZ501834A (en) 2002-05-31
PL337940A1 (en) 2000-09-11

Similar Documents

Publication Publication Date Title
SE9702706D0 (sv) Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
BR9813767A (pt) Processo e composição para tratar glaucoma de glc1a
TWI255713B (en) Method for treating meibomian gland disease
PT868186E (pt) Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular
LU92509I2 (fr) Travoprost et ses dérivés pharmaceutiquement acceptables (TRAVATAN)
EP1225168B8 (en) Prostaglandin-F-2 alpha derivative for the treatment of glaucoma or ocular hypertension
BRPI0418245A (pt) nitróxi-derivados de prostaglandina
CA2315829A1 (en) Angiostatic agents and compositions for controlling ocular hypertension
AU5446299A (en) Medicinal compositions for treating eye diseases
ATE359794T1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
AU5436198A (en) 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
ATE162074T1 (de) Oculare hypotensive mittel
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
AU2001278708A1 (en) Adenosine derivatives and use thereof
WO2000038667A3 (en) Prostaglandin e agonists for treatment of glaucoma
EP0979652A4 (en) CURATIVE COMPOSITION OF INTRAOCULAR HYPERTENSION OR GLAUCOMA
BR0017158A (pt) Agonistas de 5ht2 para controlar a iop e tratar o glaucoma
ES2079872T3 (es) Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina.
BR9812085A (pt) &#34;método para a sìntese de derivados de quinolina&#34;
FR2702150B1 (fr) Application de dérivés de 2H-1,2-4-benzothiadiazine-3(4H)-one-1,1-dioxyde comme antagonistes non compétitifs du récepteur NMDA.
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
SE0002211D0 (sv) Methods and compositions for prevention of myopia
NO980058L (no) Opthalmiske preparater
PT1021184E (pt) Utilizacao de flunarizina para o tratamento topico da hipertensao ocular

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1912 DE 28/08/2007.